Form 8-K - Current report:
SEC Accession No. 0001193125-25-087237
Filing Date
2025-04-21
Accepted
2025-04-21 16:16:42
Documents
15
Period of Report
2025-04-21
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d942664d8k.htm   iXBRL 8-K 46593
2 EX-3.1 d942664dex31.htm EX-3.1 8324
3 EX-3.2 d942664dex32.htm EX-3.2 82285
  Complete submission text file 0001193125-25-087237.txt   286613

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA cmrx-20250421.xsd EX-101.SCH 2853
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE cmrx-20250421_lab.xml EX-101.LAB 18739
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cmrx-20250421_pre.xml EX-101.PRE 11709
18 EXTRACTED XBRL INSTANCE DOCUMENT d942664d8k_htm.xml XML 3870
Mailing Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713
Business Address 2505 MERIDIAN PARKWAY, SUITE 100 DURHAM NC 27713 919.806.1074
CHIMERIX INC (Filer) CIK: 0001117480 (see all company filings)

EIN.: 330903395 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35867 | Film No.: 25853373
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)